Management of pregnancy in women with rheumatoid arthritis
Rheumatoid arthritis (RA) disease activity may improve during pregnancy but postpartum flares are common. Patients taking disease-modifying antirheumatic drugs should be counselled about effective contraception. Knowledge about drug safety in pregnancy is limited but the Therapeutic Goods Administra...
| Main Authors: | , , , |
|---|---|
| Format: | Journal Article |
| Published: |
2016
|
| Online Access: | http://hdl.handle.net/20.500.11937/5716 |
| _version_ | 1848744874502782976 |
|---|---|
| author | Ngian, G. Briggs, Andrew Ackerman, I. Van Doornum, S. |
| author_facet | Ngian, G. Briggs, Andrew Ackerman, I. Van Doornum, S. |
| author_sort | Ngian, G. |
| building | Curtin Institutional Repository |
| collection | Online Access |
| description | Rheumatoid arthritis (RA) disease activity may improve during pregnancy but postpartum flares are common. Patients taking disease-modifying antirheumatic drugs should be counselled about effective contraception. Knowledge about drug safety in pregnancy is limited but the Therapeutic Goods Administration categories and online resources are a guide to the data currently available. Begin prepregnancy counselling as early as possible to allow for cessation of teratogenic medications and optimisation of RA disease control. For unplanned pregnancies, cease teratogenic medications immediately and refer to a genetic counsellor and maternal–fetal medicine specialist for risk assessment and advice. |
| first_indexed | 2025-11-14T06:08:24Z |
| format | Journal Article |
| id | curtin-20.500.11937-5716 |
| institution | Curtin University Malaysia |
| institution_category | Local University |
| last_indexed | 2025-11-14T06:08:24Z |
| publishDate | 2016 |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | curtin-20.500.11937-57162017-09-13T14:39:15Z Management of pregnancy in women with rheumatoid arthritis Ngian, G. Briggs, Andrew Ackerman, I. Van Doornum, S. Rheumatoid arthritis (RA) disease activity may improve during pregnancy but postpartum flares are common. Patients taking disease-modifying antirheumatic drugs should be counselled about effective contraception. Knowledge about drug safety in pregnancy is limited but the Therapeutic Goods Administration categories and online resources are a guide to the data currently available. Begin prepregnancy counselling as early as possible to allow for cessation of teratogenic medications and optimisation of RA disease control. For unplanned pregnancies, cease teratogenic medications immediately and refer to a genetic counsellor and maternal–fetal medicine specialist for risk assessment and advice. 2016 Journal Article http://hdl.handle.net/20.500.11937/5716 10.5694/mja15.00365 fulltext |
| spellingShingle | Ngian, G. Briggs, Andrew Ackerman, I. Van Doornum, S. Management of pregnancy in women with rheumatoid arthritis |
| title | Management of pregnancy in women with rheumatoid arthritis |
| title_full | Management of pregnancy in women with rheumatoid arthritis |
| title_fullStr | Management of pregnancy in women with rheumatoid arthritis |
| title_full_unstemmed | Management of pregnancy in women with rheumatoid arthritis |
| title_short | Management of pregnancy in women with rheumatoid arthritis |
| title_sort | management of pregnancy in women with rheumatoid arthritis |
| url | http://hdl.handle.net/20.500.11937/5716 |